Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
ACADIA Pharmaceuticals Inc. (ACAD) had Return on Investments of 22.29% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$283.99M |
|
$273.57M |
|
$26.23M |
|
$257.76M |
|
$266.60M |
|
$17.39M |
|
$8.93M |
|
$26.32M |
|
$26.32M |
|
$273.57M |
|
$273.57M |
|
$273.57M |
|
$273.57M |
|
$17.39M |
|
$19.65M |
|
168.36M |
|
169.92M |
|
$1.62 |
|
$1.61 |
|
| Balance Sheet Financials | |
$1.06B |
|
$7.51M |
|
$502.08M |
|
$1.56B |
|
$277.11M |
|
-- |
|
$59.69M |
|
$336.81M |
|
$1.23B |
|
$1.12B |
|
$1.23B |
|
170.31M |
|
| Cash Flow Statement Financials | |
$109.84M |
|
$-302.56M |
|
$49.88M |
|
$328.36M |
|
$185.54M |
|
$-142.82M |
|
$52.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
90.77% |
|
6.12% |
|
6.12% |
|
-- |
|
9.27% |
|
96.33% |
|
$105.15M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.76 |
|
1.92 |
|
46.98 |
|
22.29% |
|
24.46% |
|
17.49% |
|
|
Return on Investments |
22.29% |
$7.21 |
|
$0.62 |
|
$0.65 |
|